✦ LIBER ✦

1162 RIBAVIRIN DOSE MODIFICATION IN TREATMENT-NAIVE AND PREVIOUSLY TREATED PATIENTS WHO RECEIVED TELAPREVIR COMBINATION TREATMENT: NO IMPACT ON SUSTAINED VIROLOGIC RESPONSE IN PHASE 3 STUDIES

✍ Scribed by Sulkowski, M.S.; Roberts, S.; Afdhal, N.; Andreone, P.; Diago, M.; Pol, S.; Poordad, F.; Zeuzem, S.; Bengtsson, L.; Luo, D.; Witek, J.; Adda, N.

Book ID: 123521668
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 77 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(12)61174-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

594 Ribavirin Dose Modification in Treat

594 Ribavirin Dose Modification in Treatment-NaïVE and Previously Treated Patients Who Received Telaprevir Combination Treatment: No Impact on Sustained Virologic Response in Phase 3 Studies

✍ Sulkowski, Mark; Roberts, Stuart K.; Afdhal, Nezam H.; Andreone, Pietro; Diago, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 98 KB

P1120 PREDICTION OF SUSTAINED VIROLOGIC

P1120 PREDICTION OF SUSTAINED VIROLOGIC RESPONSE IN TREATMENT-NAIVE CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS TREATED WITH TELAPREVIR PLUS PEGYLATED INTERFERON AND RIBAVIRIN IN PHASE 3 TRIALS

✍ Zeuzem, S.; Demasi, R.; Foster, G.R.; Buti, M.; Baldini, A.; Luo, D.; Witek, J.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Anemia Had No Effect on Efficacy Outcome

Anemia Had No Effect on Efficacy Outcomes in Treatment-NaïVE Patients Who Received Telaprevir-Based Regimen in the Advance and Illuminate Phase 3 Studies

✍ Poordad, Fred ;Sulkowski, Mark ;Reddy, Rajender ;Di Bisceglie, Adrian M. ;Zeuzem 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 829 KB

477 ANEMIA HAD NO EFFECT ON EFFICACY OUT

477 ANEMIA HAD NO EFFECT ON EFFICACY OUTCOMES IN TREATMENT-NAIVE PATIENTS WHO RECEIVED TELAPREVIR-BASED REGIMEN IN THE ADVANCE AND ILLUMINATE PHASE 3 STUDIES

✍ M.S. Sulkowski; R. Reddy; N.H. Afdhal; A.M. Di Bisceglie; S. Zeuzem; F. Poordad; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 99 KB

P1126 IMPACT OF SAFETY-RELATED DOSE REDU

P1126 IMPACT OF SAFETY-RELATED DOSE REDUCTIONS AND DISCONTINUATIONS (SR-RD) ON SUSTAINED VIROLOGICAL RESPONSE (SVR) IN TREATMENT-NAIVE CHRONIC HEPATITIS C PATIENTS RECEIVING PEGINTERFERON ALFA-2a/RIBAVIRIN: RESULTS FROM GUARD-C

✍ Foster, G.R.; Coppola, C.; Curescu, M.; Derbala, M.; Esmat, G.; Ferenci, P.; Fli 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 56 KB